Literature DB >> 29777835

Combined bacteriophages and antibiotics as an efficient therapy against VRE Enterococcus faecalis in a mouse model.

Daniel Gelman1, Shaul Beyth2, Vanda Lerer3, Karen Adler4, Ronit Poradosu-Cohen5, Shunit Coppenhagen-Glazer6, Ronen Hazan7.   

Abstract

Clinical applications of bacteriophage therapy have been recently gathering significant attention worldwide, used mostly as rescue therapy in cases of near-fatal antibiotic failure. Thus, clinically relevant in-vivo models presenting both short- and long-term implications of phage therapy given as rescue treatment for fulminant infections are of highest importance. In this study, a cocktail consisting of two lytic bacteriophages was used to evaluate the therapeutic efficacy of phage therapy as a rescue treatment for severe septic peritonitis in a mouse model. We established that a single injection of the bacteriophage cocktail was sufficient to completely reverse a 100% mortality trend caused by Vancomycin-Resistant Enterococcus faecalis, with significant improvement in both the clinical state and laboratory test results, and without harmful effects on the microbiome. The combination of bacteriophages with a suboptimal antibiotic regimen imparts an additional beneficial effect on the treatment success.
Copyright © 2018 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  EFDG1; EFLK1; Mouse peritonitis model; Phage therapy; Phage-antibiotic combination; VRE Enterococcus faecalis

Mesh:

Substances:

Year:  2018        PMID: 29777835     DOI: 10.1016/j.resmic.2018.04.008

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  23 in total

1.  Enterococcus phage Nonaheksakonda infecting clinical isolates of Enterococcus faecalis represents a new lineage in the family Siphoviridae.

Authors:  Nikoline S Olsen; Katrine Johansen Nielsen; Maja Plöger; Witold Kot; Lars Hestbjerg Hansen
Journal:  Arch Virol       Date:  2021-01-03       Impact factor: 2.574

Review 2.  Novel Strategies for the Management of Vancomycin-Resistant Enterococcal Infections.

Authors:  German A Contreras; Jose M Munita; Cesar A Arias
Journal:  Curr Infect Dis Rep       Date:  2019-05-22       Impact factor: 3.725

3.  Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis.

Authors:  Tatsuma Kishimoto; Waka Ishida; Ken Fukuda; Isana Nakajima; Takashi Suzuki; Jumpei Uchiyama; Shigenobu Matsuzaki; Daisuke Todokoro; Masanori Daibata; Atsuki Fukushima
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

4.  Mining and Statistical Modeling of Natural and Variant Class IIa Bacteriocins Elucidate Activity and Selectivity Profiles across Species.

Authors:  Daniel T Tresnak; Benjamin J Hackel
Journal:  Appl Environ Microbiol       Date:  2020-10-28       Impact factor: 4.792

Review 5.  Molecular mechanisms of enterococcal-bacteriophage interactions and implications for human health.

Authors:  Gregory S Canfield; Breck A Duerkop
Journal:  Curr Opin Microbiol       Date:  2020-07-08       Impact factor: 7.934

6.  Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying Bacteriophage and Daptomycin Susceptibilities.

Authors:  Taylor Morrisette; Katherine L Lev; Razieh Kebriaei; Jacinda C Abdul-Mutakabbir; Kyle C Stamper; Sandra Morales; Susan M Lehman; Gregory S Canfield; Breck A Duerkop; Cesar A Arias; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

7.  Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation-A proof-of-principle study in a P. aeruginosa lung infection model.

Authors:  Yu Lin; Diana Quan; Rachel Yoon Kyung Chang; Michael Y T Chow; Yuncheng Wang; Mengyu Li; Sandra Morales; Warwick J Britton; Elizabeth Kutter; Jian Li; Hak-Kim Chan
Journal:  Eur J Pharm Biopharm       Date:  2020-11-27       Impact factor: 5.571

Review 8.  Dietary Modulation of Bacteriophages as an Additional Player in Inflammation and Cancer.

Authors:  Luigi Marongiu; Markus Burkard; Sascha Venturelli; Heike Allgayer
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

Review 9.  Nanobiosystems for Antimicrobial Drug-Resistant Infections.

Authors:  Foteini Gkartziou; Nikolaos Giormezis; Iris Spiliopoulou; Sophia G Antimisiaris
Journal:  Nanomaterials (Basel)       Date:  2021-04-22       Impact factor: 5.076

10.  Enterococcus faecalis Countermeasures Defeat a Virulent Picovirinae Bacteriophage.

Authors:  Julien Lossouarn; Arnaud Briet; Elisabeth Moncaut; Sylviane Furlan; Astrid Bouteau; Olivier Son; Magali Leroy; Michael S DuBow; François Lecointe; Pascale Serror; Marie-Agnès Petit
Journal:  Viruses       Date:  2019-01-10       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.